Adobe, Ulta Beauty, Lennar Report Earnings March 12, 2026

Adobe, Ulta Beauty, Lennar, and other companies report earnings on March 12, 2026. See expected EPS and year-over-year changes.

Several companies, including Adobe Inc., Ulta Beauty, Inc., and Lennar Corporation, are scheduled to release their earnings reports after the market closes on March 12, 2026. Investors will be closely watching these reports for insights into company performance and sector trends.

Imagem
Imagem

What You Need to Know

  • Adobe Inc.(ADBE) is expected to report earnings per share of $4.85, a 13.32% increase year-over-year.
  • Wheaton Precious Metals Corp.(WPM) anticipates earnings per share of $0.93, a significant 111.36% increase from the previous year.
  • Ulta Beauty, Inc.(ULTA) forecasts earnings per share of $8.00, a slight 5.44% decrease compared to last year.
  • Lennar Corporation(LEN) projects earnings per share of $0.96, representing a 55.14% decrease year-over-year.

Key Company Earnings Previews

Adobe Inc. (ADBE)

Adobe Inc., a computer software company, is set to report for the quarter ending February 28, 2026. The consensus earnings per share forecast from 12 analysts is $4.85, marking a 13.32% increase from the same quarter last year. ADBE has consistently beaten expectations in the past year, with its strongest performance in the fourth calendar quarter, exceeding the consensus by 3.64%. According to Zacks Investment Research, ADBE‘s 2026 Price to Earnings ratio stands at 14.43, compared to an industry average of 17.70.

Wheaton Precious Metals Corp. (WPM)

Wheaton Precious Metals Corp. will report for the quarter ending December 31, 2025. Analysts project earnings per share of $0.93, an impressive 111.36% increase year-over-year. In the past year, WPM has met analyst expectations once and surpassed them in the other three quarters. Zacks Investment Research notes that WPM‘s 2025 Price to Earnings ratio is 54.46, contrasting with an industry ratio of -61.50, suggesting higher earnings growth potential compared to peers.

Ulta Beauty, Inc. (ULTA)

Ulta Beauty, Inc., a retail company, is reporting for the quarter ending January 31, 2026. The consensus earnings per share forecast from 14 analysts is $8.00, a 5.44% decrease from the prior year. ULTA has a strong track record of beating earnings expectations each quarter over the past year, with its highest beat of 12.72% occurring in the fourth calendar quarter. Zacks Investment Research indicates that ULTA‘s 2026 Price to Earnings ratio is 25.46, slightly above the industry ratio of 23.30, implying potentially higher earnings growth.

Lennar Corporation (LEN)

Lennar Corporation, a building company, is scheduled to report for the quarter ending February 28, 2026. The consensus earnings per share forecast from 7 analysts is $0.96, a significant 55.14% decrease compared to the same quarter last year. Zacks Investment Research reports that LEN‘s 2026 Price to Earnings ratio is 14.88, compared to an industry ratio of 13.30, suggesting potentially higher earnings growth relative to its competitors.

Other Notable Earnings Reports

Rubrik, Inc. (RBRK)

Rubrik, Inc., an internet software company, is reporting for the quarter ending January 31, 2026. The consensus earnings per share forecast from 9 analysts is $-0.53, a 13.11% increase year-over-year. RBRK has exceeded expectations in every quarter over the past year, with its highest beat of 51.61% in the fourth calendar quarter. Zacks Investment Research notes RBRK‘s 2026 Price to Earnings ratio at -31.43 versus an industry ratio of 66.90.

ServiceTitan, Inc. (TTAN)

ServiceTitan, Inc., also an internet software company, is reporting for the quarter ending January 31, 2026. The consensus earnings per share forecast from 5 analysts is $-0.30, a 77.78% increase compared to the previous year. Zacks Investment Research reports TTAN‘s 2026 Price to Earnings ratio at -84.40, against an industry ratio of 66.90.

SentinelOne, Inc. (S)

SentinelOne, Inc., a security company, is reporting for the quarter ending January 31, 2026. The consensus earnings per share forecast from 11 analysts is $-0.16, a 20.00% increase year-over-year. Zacks Investment Research reports that S‘s 2026 Price to Earnings ratio is -21.45, compared to an industry ratio of -520.10, indicating potentially higher earnings growth.

Mach Natural Resources LP (MNR)

Mach Natural Resources LP, an oil (US exp & production) company, is reporting for the quarter ending December 31, 2025. The consensus earnings per share forecast from 4 analysts is $0.26, a 58.06% decrease year-over-year. MNR missed the consensus earnings per share in the first calendar quarter of 2025 by -1.45%. Zacks Investment Research reports MNR‘s 2025 Price to Earnings ratio at 9.64 versus an industry ratio of 68.20.

Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics, Inc., a biomedical (gene) company, is reporting for the quarter ending December 31, 2025. The consensus earnings per share forecast from 4 analysts is $-0.57, a 41.84% increase year-over-year. MLYS has beaten expectations every quarter in the past year, with its highest beat of 21.21% in the third calendar quarter. The stock’s “days to cover” exceeds 11 days. Zacks Investment Research reports MLYS‘s 2025 Price to Earnings ratio at -11.46 versus an industry ratio of -5.60.

EverCommerce Inc. (EVCM)

EverCommerce Inc., an internet software company, is reporting for the quarter ending December 31, 2025. The consensus earnings per share forecast from 2 analysts is $0.04, a 157.14% increase year-over-year. The stock’s “days to cover” exceeds 12 days. Zacks Investment Research reports EVCM‘s 2025 Price to Earnings ratio at 111.09 versus an industry ratio of 66.90, suggesting potentially higher earnings growth.

Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics, Inc., a medical products company, is reporting for the quarter ending December 31, 2025. The consensus earnings per share forecast from 4 analysts is $-0.51, a 218.75% decrease year-over-year. Zacks Investment Research reports CAPR‘s 2025 Price to Earnings ratio at -15.69 versus an industry ratio of 19.60.

Nektar Therapeutics (NKTR)

Nektar Therapeutics, a drug company, is reporting for the quarter ending December 31, 2025. The consensus earnings per share forecast from 6 analysts is $-2.76, a 22.67% decrease year-over-year. Zacks Investment Research reports NKTR‘s 2025 Price to Earnings ratio at -7.03 versus an industry ratio of -9.20, implying potentially higher earnings growth.

Nasdaq logo
Nasdaq Inc. logo.

Fonte: Nasdaq


Images and videos belong to their respective owners.
This content may include information compiled from external sources and produced with the assistance of AI tools under editorial supervision.

Need to adjust credit or request removal? Click here.